Skip to main content
. 2020 Nov 16;77:591–594. doi: 10.1016/j.ijscr.2020.11.063

Fig. 1.

Fig. 1

Response to Combination Pembrolizumab and Tavokinogene Telseplasmid (TAVO) Electroporation Therapy.

A. Hilar lymphadenopathy before and after therapy.

B. Liver metastasis before and after therapy.

C. Left groin target lesion was the lesion used for treatment, seen before and after therapy.